198 results on '"ARMENDáRIZ-BORUNDA, J."'
Search Results
2. Nuclear abnormalities in buccal mucosa cells of patients with type I and II diabetes treated with folic acid
3. Pirfenidone prevents rat esophageal stricture formation
4. Pirfenidone regulates antioxidant response via NRF2 in an experimental model of hepatocellular carcinoma
5. Moringa oleifera decreases biomarkers of oxidative stress in a murine NASH model
6. The gut microbiota and key parameters associated with MAFLD are modified by MEXMIX
7. Dietary supplementation with methyl donors improves physiopathological conditions of NAFLD in a murine model
8. Pirfenidone ameliorates MAFLD by improving insulin sensitivity and reducing epididymal fat
9. The administration of pirfenidone modifies the expression of JMJD2B in a murine model of NASH
10. Liquid biopsy of patients with advanced liver fibrosis reveals the association of methylation in CpGs and miRNAs expression with the degree of severity
11. HIF-1α expression in the hippocampus and peripheral macrophages after glutamate-induced excitotoxicity
12. New Amino Acid Changes in Drug Resistance Sites and HBsAg in Hepatitis B Virus Genotype H
13. Delivery of Anti-IFNAR1 shRNA to Hepatic Cells Decreases IFNAR1 Gene Expression and Improves Adenoviral Transduction and Transgene Expression
14. Combinatorial gene therapy induces regression of hepatic encephalopathy
15. Molecular diagnosis of Chagas' disease and use of an animal model to study parasite tropism
16. Prolonged-release pirfenidone decreases hepatic miRNAs expression in a NAFLD/NASH experimental model
17. Analysis of the molecular interaction of pirfenidone with PPAR-gamma and effects on the beta-catenine pathway in HEPG2 line
18. Molecular, histological and biochemical changes in a NASH murine model whit a diet high in fats and sugars
19. Cellular and molecular characterization of the pirfenidone effects on an hepatocarcinogésis experimental model
20. Prolonged-release pirfenidone prevents myocardial fibrosis in a mouse nonalcoholic steatohepatitis model
21. Moringa oleífera decreases insulin resistance, novo lipogenesis and modifies the expression of mirnas in a non-alcoholic esteatohepatitis model
22. Immunosuppressive activity of proteases in cervical carcinoma
23. A pilot study in patients with established advanced liver fibrosis using pirfenidone
24. Nitric oxide synthases inhibition results in renal failure improvement in cirrhotic rats
25. TH1/TH2 cytokine profile, metalloprotease-9 activity and hormonal status in pregnant rheumatoid arthritis and systemic lupus erythematosus patients
26. Changes in NMDA-receptor gene expression are associated with neurotoxicity induced neonatally by glutamate in the rat brain
27. Buccal micronucleus cytome assay of populations under chronic heavy metal and other metal exposure along the Santiago River, Mexico
28. Human adipose derived stem cells reduce fibrosis in an experimental model of chronic kidney damage
29. Pirfenidone maintains nuclear Nrf2 activation and reduces proinflammatory and fibrogenic effects induced by oxidative stress in human hepatic stellate cells (HSC)
30. 311 - Human adipose derived stem cells reduce fibrosis in an experimental model of chronic kidney damage
31. SAT-346 - Prolonged-release pirfenidone is a dual activator for PPARalpha and PPARgamma and improves NASH features induced by high fat/carbohydrate diet
32. P428 5-METHYL-1-PHENYL-2-(1H)-PYRIDONE TREATMENT IMPROVES MARKERS OF HEPATIC FUNCTION AND FIBROSIS IN STEATOSIS INDUCED BY HIGH FAT/CARBOHYDRATE DIET
33. 1049 AD-MMP8 ADMINISTRATION IN SKELETAL MUSCLE DECREASED THE FIBROSIS PERCENTAGE, TGF-B, COL-1 AND CTGF IN EXPERIMENTAL LIVER FIBROSIS
34. Ethylenediaminetetraacetic acid induces antioxidant and anti-inflammatory activities in experimental liver fibrosis
35. 1045 PIRFENIDONE MAINTAINS NUCLEAR NRF2 ACTIVATION AND REDUCES PROINFLAMMATORY AND FIBROGENIC EFFECTS INDUCED BY OXIDATIVE STRESS IN HUMAN HEPATIC STELLATE CELLS (HSC)
36. Combinatorial gene therapy induces regression of hepatic encephalopathy
37. 736 NRF2 EXPRESSION DOES NOT CORRELATE WITH ANTIOXIDANTS ENZYMES IN EXPERIMENTAL CHOLESTASIS
38. Circulating TNFRI and TNFRII levels correlated with the disease activity score (DAS28) in rheumatoid arthritis
39. P632 INTRAMUSCULAR HUMAN MMP-8 GENE DELIVERY PREVENTS EXPERIMENTAL LIVER FIBROSIS
40. P591 IMPROVEMENT OF TRANSDUCTION WITH Ad-GFP VECTOR MEDIATED BY siRNA- IFN-a IN HEPATIC CELLS
41. P541 QUERCETIN INDUCES HSC APOPTOSIS, UP-REGULATION OF CB2 AND DOWN-REGULATION OF CB1 IN AN ANIMAL MODEL OF LIVER FIBROSIS
42. T[sub H] 1/T[sub H] 2 cytokine profile, metalloprotease-9 activity and hormonal status in pregnant rheumatoid arthritis and systemic lupus erythematosus patients.
43. NMDAR-2C and 2D subunits gene expression is induced in brain by neonatal exposure of monosodium l-glutamate to adult rats
44. 423 TREATMENT WITH PIRFENIDONE PRODUCES AN IMPORTANT REDUCTION IN NECROINFLAMMATION SCORE, FIBROSIS INDEX AND INCREASED GENE EXPRESSION OF CB2 IN PATIENTS WITH LIVER CIRRHOSIS
45. 284 PIRFENIDONE LIMITS TH2 FIBROGENIC RESPONSE IN EXPERIMENTAL LIVER FIBROSIS VIA P38 MAPK INHIBITION
46. 544 ADENOVIRUS DELIVERY OF TBRIIDCYT UP-REGULATES TRANSCRIPTIONAL REPRESSOR SNON, DECREASES MMP-2 IN HSC AND PREVENTS ESTABLISHMENT OF LIVER FIBROSIS
47. 483 EFFECT OF PIRFENIDONE IN TH1/TH2 RESPONSE IN EXPERIMENTAL LIVER FIBROSIS
48. [385] LIVER FIBROSIS REVERSION STRATEGY USING ad-MMP8 AND ad-uPA ADENOVIRAL VECTORS
49. [318] PLASMIN HAS AN IMPORTANT ROLE IN SnoN MODULATION IN HSC
50. 381 Effect of the preimmunization status and transient immunosupression with cyclosporin a in transduction efficiency of adenovectors in cirrhotic rats
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.